Abstract |
Based on the anticonvulsant and neuroprotective properties of adenosine, and based on the long-term survival potential of stem cell derived brain implants, adenosine releasing stem cells may constitute a novel tool for the treatment of epilepsy. Pluripotency and unlimited self-renewal make embryonic stem (ES) cells a particularly versatile donor source for cell transplantation. With the aim to test the feasibility of a stem cell-based delivery system for adenosine, both alleles of adenosine kinase (ADK), the major adenosine-metabolizing enzyme, were disrupted by homologous recombination in ES cells. Adk-/- ES cells were subjected to a glial differentiation protocol and, as a result, gave rise to proliferating glial precursors, which could be further differentiated into mature astrocytes and oligodendrocytes. Thus, a lack of ADK does not compromise the glial differentiation potential of ES cells. The Adk-/- ES cells yielded glial populations with an adenosine release of up to 40.1 +/- 6.0 ng per 10(5) cells per hour, an amount considered to be sufficient for seizure suppression. Our findings indicate that Adk-/- ES cells constitute a potential source for therapeutic adenosine releasing grafts.
|
Authors | Denise E Fedele, Peter Koch, Louis Scheurer, Elizabeth M Simpson, Hanns Möhler, Oliver Brüstle, Detlev Boison |
Journal | Neuroscience letters
(Neurosci Lett)
Vol. 370
Issue 2-3
Pg. 160-5
(Nov 11 2004)
ISSN: 0304-3940 [Print] Ireland |
PMID | 15488315
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Glial Fibrillary Acidic Protein
- Growth Substances
- Intermediate Filament Proteins
- Nerve Tissue Proteins
- Nes protein, mouse
- Nestin
- O Antigens
- Adenosine Kinase
- Adenosine
|
Topics |
- Adenosine
(metabolism)
- Adenosine Kinase
(deficiency, genetics)
- Analysis of Variance
- Animals
- Blotting, Western
(methods)
- Cell Differentiation
(drug effects, physiology)
- Cells, Cultured
- Chromosome Mapping
(methods)
- Embryo, Mammalian
- Fluorescent Antibody Technique
(methods)
- Gene Expression Regulation, Developmental
(drug effects)
- Genetic Engineering
- Glial Fibrillary Acidic Protein
(immunology)
- Growth Substances
(pharmacology)
- Intermediate Filament Proteins
(metabolism)
- Mice
- Nerve Tissue Proteins
(metabolism)
- Nestin
- Neuroglia
(drug effects, metabolism)
- O Antigens
(metabolism)
- Oligodendroglia
(metabolism)
- Polymerase Chain Reaction
(methods)
- Stem Cell Transplantation
- Stem Cells
(physiology)
|